A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer.

Journal: BJU international
PMID:

Abstract

OBJECTIVES: To assess artificial intelligence (AI) ability to evaluate intraprostatic prostate cancer (PCa) on prostate-specific membrane antigen positron emission tomography (PSMA PET) scans prior to active treatment (radiotherapy or prostatectomy).

Authors

  • Jianliang Liu
    EJ Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Victoria, Australia.
  • Thomas P Cundy
  • Dixon T S Woon
    EJ Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Victoria, Australia.
  • Nanadakishor Desai
    Department of Electrical and Electronic Engineering, University of Melbourne, Melbourne, Victoria, Australia.
  • Marimuthu Palaniswami
  • Nathan Lawrentschuk
    Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre and Olivia Newton-John Cancer Research Institute, Austin Hospital, Melbourne, Victoria, Australia.